- Home
- FBIO vs GDL Comparison
FBIO vs GDL Comparison
Compare FBIO & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- GDL
- Stock Information
- Founded
- FBIO 2006
- GDL 2006
- Country
- FBIO United States
- GDL United States
- Employees
- FBIO N/A
- GDL N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- GDL Investment Managers
- Sector
- FBIO Health Care
- GDL Finance
- Exchange
- FBIO Nasdaq
- GDL Nasdaq
- Market Cap
- FBIO 88.7M
- GDL 95.6M
- IPO Year
- FBIO N/A
- GDL N/A
- Fundamental
- Price
- FBIO $3.00
- GDL $8.56
- Analyst Decision
- FBIO Strong Buy
- GDL
- Analyst Count
- FBIO 2
- GDL 0
- Target Price
- FBIO $16.50
- GDL N/A
- AVG Volume (30 Days)
- FBIO 1.6M
- GDL 11.2K
- Earning Date
- FBIO 11-13-2025
- GDL 01-01-0001
- Dividend Yield
- FBIO N/A
- GDL 6.02%
- EPS Growth
- FBIO N/A
- GDL N/A
- EPS
- FBIO N/A
- GDL N/A
- Revenue
- FBIO $59,301,000.00
- GDL N/A
- Revenue This Year
- FBIO $49.84
- GDL N/A
- Revenue Next Year
- FBIO $42.47
- GDL N/A
- P/E Ratio
- FBIO N/A
- GDL N/A
- Revenue Growth
- FBIO N/A
- GDL N/A
- 52 Week Low
- FBIO $1.33
- GDL $7.65
- 52 Week High
- FBIO $4.20
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- FBIO 45.50
- GDL 51.52
- Support Level
- FBIO $2.72
- GDL $8.51
- Resistance Level
- FBIO $3.24
- GDL $8.59
- Average True Range (ATR)
- FBIO 0.29
- GDL 0.07
- MACD
- FBIO -0.13
- GDL -0.00
- Stochastic Oscillator
- FBIO 22.61
- GDL 63.37
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.